MustGrow Biologics (MGROF) AI Stock Analysis

MustGrow Biologics

(Other OTC:MGROF)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Low LeverageModest leverage reduces near-term financial risk and limits interest-related pressure on cash flow. This gives MustGrow more balance-sheet flexibility than a highly indebted company while it works to improve commercialization, revenue scale, and operating performance.

Negative Factors

Revenue ContractionThe sharp TTM revenue contraction shows that commercial momentum remains inconsistent and that the business has not yet established a dependable growth trajectory. Continued volatility can restrict operating leverage, weaken partner confidence, and make it harder to fund research and regulatory work internally.

MustGrow Biologics (MGROF) vs. SPDR S&P 500 ETF (SPY)

Market Cap: $18.66M
Dividend Yield: ―
Average Volume (3M): 6,989
Price to Earnings (P/E): -3.7
Beta (1Y): 0.32
Revenue Growth: -53.75%
EPS Growth: 9.88%
Country: US
Employees: 8
Sector: Basic Materials
Sector Strength: 61
Industry: Agricultural Inputs

MustGrow Biologics Business Overview & Revenue Model

Company Description

MustGrow Biologics Corp. is an agricultural biotechnology enterprise specializing in the creation and commercialization of natural crop protection solutions. These offerings, including biopesticides, biofumigants, and bioherbicides, are uniquely deri...

MustGrow Biologics Peers Comparison

Overall Rating

UnderperformOutperform

Sector (61)

Financial Indicators

MGROF against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
TSE:NTR	71Outperform	CAD 46.17B	14.05	9.38%	3.17%	7.77%	76.65%
Sector *	61Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%
TSE:PLAN	60Neutral	CAD 34.01M	41.22	5.11%	―	18.41%	-71.10%
TSE:NPK	48Neutral	CAD 38.38M	-2.90	-59.51%	―	-20.60%	-8.43%
TSE:GSP	40Underperform	CAD 62.19M	-22.81	-27.00%	―	―	13.85%

* Basic Materials Sector Average

Performance Comparison

MGROF and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
MGROF	Mustgrow Biologics Corp.	0.27	-0.22	-45.13%
TSE:PLAN	Progressive Planet Solutions Inc.	0.30	0.02	5.17%
TSE:GSP	Gensource Potash	0.13	0.07	100.00%
TSE:NPK	Verde Agritech	0.68	-0.45	-39.82%
TSE:NTR	Nutrien	96.96	22.75	30.65%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

MustGrow Biologics AI Stock Analysis